532523:BOM
Biocon Ltd
350,00Â INR
arrow_downward
−0,43%(−1,50) 1 d
16 okt., 15:30:00 GMT+5:30 · INR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för 532523 …
Öppen
352,95Â INR
Högt
352,95Â INR
LÃ¥gt
348,10Â INR
Börsvärde
568,79Â md
Genomsn. vol.
692,61Â tn
Volym
668,34Â tn
Utdelning
0,14Â %
Kvartalsvis utdelning
0,13Â INR
Ex-utdelningsdatum
3 juli 2026
P/E-tal
103,62
52v högst
447,00Â INR
52v lägst
337,95Â INR
EPS
3,38Â INR
Utestående aktier
600,00Â mn
Antal anställda
16Â tn
Öppen
352,95Â INR
Högt
352,95Â INR
LÃ¥gt
348,10Â INR
Börsvärde
568,79Â md
Genomsn. vol.
692,61Â tn
Volym
668,34Â tn
Utdelning
0,14Â %
Kvartalsvis utdelning
0,13Â INR
Ex-utdelningsdatum
3 juli 2026
P/E-tal
103,62
52v högst
447,00Â INR
52v lägst
337,95Â INR
EPS
3,38Â INR
Utestående aktier
600,00Â mn
Antal anställda
16Â tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
HurBra.se
·
för 2 dagar sedan
USA-börsen 15 oktober 2026: Vård lyfte, AI pressades
Simply Wall Street
·
för 30 minuter sedan
Warner Music Group (WMG) Draws Fresh Interest, Is A 17% Discount Still On Offer?
The Motley Fool
·
för 29 minuter sedan
Should You Invest in the S&P 500 Right Now or Wait? There's 1 Clear Answer
Yahoo Finance
·
för 4 timmar sedan
Michael Burry Warns Stock Market Could Be Months Away From A 2000-Style Reckoning — ‘The Preconditions Seem Set For Fireworks’
Profil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Om Biocon Ltd
VdShreehas P Tambe
Anställda16,4 tn
Grundades29 nov. 1978
HuvudkontorBangalore, Karnataka, Indien
Sektor-
Webbplatsbiocon.com